Briefly, our research offers comprehensive epidemiological evidence that common variants of the ERCC4 and ERCC5 genes show association with the predisposition of bladder cancer, esophageal cancer, laryngeal cancer, uterine cancer, and gastric cancer. This evidence concerns the gene ERCC5 and urinary bladder cancer.